Induction and effector phase of allergic lung inflammation is independent of 0121/0119 and LT-beta

Corinne Ploix, Riaz I. Zuberi, Fu-Tong Liu, Monica J. Carson, David D. Lo

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The chemokines CCL2I and CCLI9, and cell bound TNF family ligand lymphotoxin beta (LTβ), have been associated with numerous chronic inflammatory diseases. A general role in chronic inflammatory diseases cannot be assumed however; in the case of allergic inflammatory disease, CCL21/CCL19 and LTβ have not been associated with the induction, recruitment, or effector function of Th2 cells nor dendritic cells to the lung. We have examined the induction of allergic inflammatory lung disease in mice deficient in CCL21/CCL19 or LTβ and found that both kinds of mice can develop allergic lung inflammation. To control for effects of priming differences in knockout mice, adoptive transfers of Th2 cells were also performed, and they showed that such effector cells had equivalent effects on airway hy per-responsiveness in both knockout background recipients. Moreover, class II positive antigen presenting cells (B cells and CDIIc+ dendritic cells) showed normal recruitment to the peribronchial spaces along with CD4 T cells. Thus, the induction of allergic responses and recruitment of both effector Th2 cells and antigen presenting cells to lung peribronchial spaces can develop independently of CCL21/CCL19 and LTβ.

Original languageEnglish (US)
Pages (from-to)85-92
Number of pages8
JournalInternational Journal of Medical Sciences
Issue number2
StatePublished - Feb 26 2009


  • Asthma
  • Chemokine
  • Dendritic cell
  • Th2

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Induction and effector phase of allergic lung inflammation is independent of 0121/0119 and LT-beta'. Together they form a unique fingerprint.

Cite this